Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?
Recommended Citation
Luzum JA, Lanfear DE. Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?. J Am Heart Assoc 2016; 5(3):003440.
Document Type
Article
Publication Date
3-28-2016
Publication Title
J Am Heart Assoc
Medical Subject Headings
Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Cost-Benefit Analysis; Humans; Perindopril; Pharmacogenetics
PubMed ID
27021567
Volume
5
Issue
3
First Page
003440
